Natrecor (nesiritide) is a new IV drug in Canada for treating patients who are hospitalized with acute heart failure
February 2008
Natrecor (nesiritide) is a new IV drug in Canada for treating patients who are hospitalized with acute heart failure.
It's the first in a class called human B-type natriuretic peptides. Natrecor is a recombinant version of this peptide...and has vasodilatory effects.
Natrecor improves circulation and shortness of breath.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive